These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. An experimental study of postvaccination and postinfectious immunity to dysenteria in guinea-pigs. Manolov DG; Kosturkov GB J Hyg Epidemiol Microbiol Immunol; 1967; 11(3):347-52. PubMed ID: 5629951 [No Abstract] [Full Text] [Related]
25. [Epidemiologic and diagnostic significance of reactivity of enteric vaccines]. MIKULINSKAIA RM; VOLOVICH NI; KRASOVITSKAIA AM Zh Mikrobiol Epidemiol Immunobiol; 1954 Nov; 11():60-2. PubMed ID: 14349270 [No Abstract] [Full Text] [Related]
26. Studies on vaccination against bacillary dysentery. 4. Oral immunization with live monotypic and combined vaccines. Mel DM; Arsić BL; Nikolić BD; Radovanić ML Bull World Health Organ; 1968; 39(3):375-80. PubMed ID: 5303905 [TBL] [Abstract][Full Text] [Related]
27. The cellular and humoral immune response after administration to the guinea pig of Shigella flexneri 2a T32--Istrati vaccinal strain by different routes. Meitert T; Radu I; Ciudin L; Pencu E; Tonciu M Arch Roum Pathol Exp Microbiol; 1978; 37(3-4):267-76. PubMed ID: 395927 [No Abstract] [Full Text] [Related]
28. [Specific vaccination against dysentery using live attenuated oral vaccine]. Rubtsov IV; Belaia IuA; Mel'nik EG; Berlin ZI Zh Mikrobiol Epidemiol Immunobiol; 1970 Jul; 47(7):58-63. PubMed ID: 5483994 [No Abstract] [Full Text] [Related]
29. [Animal method of comparative evaluation of immunizing activities of dysenterial vaccines prepared from freshly isolated and from commercial strains]. LESNIAK SV Zh Mikrobiol Epidemiol Immunobiol; 1955 Oct; (10):19-27. PubMed ID: 13282472 [No Abstract] [Full Text] [Related]
30. [Specific prevention of dysentery. 3. Elaboration of a method of preparing live dysentery vaccine for enteral use and study of its properties]. Belaia IuA; Gekker VD Zh Mikrobiol Epidemiol Immunobiol; 1969 Oct; 46(10):125-9. PubMed ID: 4992761 [No Abstract] [Full Text] [Related]
31. [Epidemic effectiveness of antidysenterial immunization with immunogen]. DUMESH MG; MILORADOVSKAIA EA Zh Mikrobiol Epidemiol Immunobiol; 1956 Mar; 27(3):12-5. PubMed ID: 13325925 [No Abstract] [Full Text] [Related]
32. Strategies for development of potential candidate Shigella vaccines. Lindberg AA; Pál T Vaccine; 1993; 11(2):168-79. PubMed ID: 8438615 [TBL] [Abstract][Full Text] [Related]
33. [Optimal conditions in preparation and application of vaccines from complete antigens. II. Immunogenic properties of vaccines]. POTAPCHIK IuA Zh Mikrobiol Epidemiol Immunobiol; 1956 Aug; 27(8):60-6. PubMed ID: 13393658 [No Abstract] [Full Text] [Related]
34. Antidysentery immunoprophylaxis in the light of current data about the pathogenicity of Shigella and the antidysentery immunity. Meitert T Arch Roum Pathol Exp Microbiol; 1984; 43(3-4):195-230. PubMed ID: 6443688 [No Abstract] [Full Text] [Related]
35. [Immunologic characteristics of Shigella sonnei in experimental conditions in white mice]. IAFAEV RKh Zh Mikrobiol Epidemiol Immunobiol; 1955 Mar; 3():43-9. PubMed ID: 14387194 [No Abstract] [Full Text] [Related]
36. [Use of antibody-producing cell test for the purpose of studying the immunologic effectiveness of Sonne dysentery vaccines]. Sergeeva GS; Elkina SI Zh Mikrobiol Epidemiol Immunobiol; 1977 Jun; (6):131-3. PubMed ID: 331778 [No Abstract] [Full Text] [Related]